[N-aсetyltransferase (NAT2) gene polymorphism and gene network analysis]

Area of Science:

• Pharmacogenomics
• Human Genetics
• Metabolomics

Background:

• Understanding xenobiotic metabolism is crucial for personalized medicine and disease risk assessment.
• The N-acetyltransferase 2 (NAT2) gene plays a key role in drug and carcinogen metabolism.
• Allelic variations in NAT2 influence individual susceptibility to diseases and environmental toxins.

Purpose of the Study:

• To determine the frequencies of two significant slow acetylator NAT2 gene variants (NAT2*5 and NAT2*7) in the indigenous Nenets population of Northern Siberia.
• To investigate the potential impact of these variants on xenobiotic metabolism within this specific ethnic group.
• To contribute to a broader understanding of genetic adaptations in indigenous Arctic populations.

Main Methods:

• Bioinformatic analysis of existing datasets related to xenobiotic metabolism.
• Genotyping of NAT2*5 (rs1801280) and NAT2*7 (rs1799931) variants.
• Population genetic analysis comparing variant frequencies with European and Asian populations.

Main Results:

• The frequencies of NAT2*5 and NAT2*7 variants in the Nenets population were found to be intermediate between those observed in European and Asian populations.
• This intermediate frequency suggests potential unique adaptive mechanisms related to xenobiotic metabolism in this group.
• A model for the distribution of these polymorphic variants was developed for the indigenous inhabitants of the Yamal region.

Conclusions:

• The NAT2 gene polymorphism frequencies in the Nenets population indicate specific adaptive features.
• These findings highlight the importance of considering ethnic-specific genetic variations in pharmacogenomics and environmental health studies.
• Further research is warranted to fully elucidate the functional implications of these NAT2 variants in the Nenets population.